PLUS THERAPEUTICS, INC. — Director's Dealing 2017

Mar 17, 2017

SEC Form 4/A — Form 4/A

Issuer: CYTORI THERAPEUTICS, INC. (CTYX)
CIK: 0001095981
Period of Report: 2017-03-08

Reporting Person: Marino Mark (Chief Medical Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-03-08	Incentive Stock Option (right to buy)	$1.55	A	31100	Acquired	2027-03-08	Common Stock (31100)	Direct

Footnotes

F1: Twenty-five percent (25%) of the option shares shall vest and become exercisable on March 8, 2018 with the remaining option shares vesting and becoming exercisable in thirty-six (36) consecutive monthly installments.